Importer of Controlled Substances Application: R & D Systems, Inc., 49580-49581 [2018-21334]
Download as PDF
49580
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices
The
companies listed below applied to be
registered as importers of various basic
SUPPLEMENTARY INFORMATION:
classes of controlled substances.
Information on previously published
notices are listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
Company
FR Docket
AMRI Rensselaer, Inc .............................................................................................................................................
S&B Pharma, Inc ....................................................................................................................................................
Cerilliant Corporation ..............................................................................................................................................
Shertech Laboratories, LLC ....................................................................................................................................
Fresenius Kabi USA, LLC .......................................................................................................................................
VHG Labs DBA LGC Standards .............................................................................................................................
Catalent Pharma Solutions, LLC ............................................................................................................................
Fisher Clinical Services, Inc ....................................................................................................................................
Anderson Brecon, Inc .............................................................................................................................................
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971.
The DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–21354 Filed 10–1–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: R & D Systems, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 1, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 1, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearings must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearings
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
DATES:
83
83
83
83
83
83
83
83
83
amozie on DSK3GDR082PROD with NOTICES1
Jkt 247001
PO 00000
Frm 00051
Fmt 4703
April 9, 2018.
July 5, 2018.
July 16, 2018.
July 23, 2018.
July 23, 2018.
July 23, 2018.
July 23, 2018.
July 23, 2018.
August 1, 2018.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
9, 2018, R & D Systems, Inc., 614
McKinley Place NE, Minneapolis,
Minnesota 55413–5541 applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
17:16 Oct 01, 2018
15176
31421
32906
34879
34878
34875
34874
34879
37525
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
Controlled substance
VerDate Sep<11>2014
FR
FR
FR
FR
FR
FR
FR
FR
FR
Published
Sfmt 4703
E:\FR\FM\02OCN1.SGM
02OCN1
1248
7118
7297
7360
7370
7391
7405
7435
7438
2270
7471
9041
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices
The company plans to import bulk
active controlled substances for
distribution to its customers for research
and analytical purposes. In reference to
drug codes marihuana (7360) and
tetrahydrocannabinols (7370) the
company plans to import a synthetic
cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–21336 Filed 10–1–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
Office of Justice Programs
[FR Doc. 2018–21334 Filed 10–1–18; 8:45 am]
Notice of Charter Renewal of the
Coordinating Council on Juvenile
Justice and Delinquency Prevention
[OJP (OJJDP) Docket No. 1751]
BILLING CODE 4410–09–P
Coordinating Council on
Juvenile Justice and Delinquency
Prevention, Justice.
ACTION: Notice of Charter Renewal.
AGENCY:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as an importer of
various classes of schedule I or II
controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
SUMMARY:
Company
FR docket
Published
Ultra Scientific Inc.
83 FR 37525
August 1, 2018.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic classes of schedule I or II
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
VerDate Sep<11>2014
17:16 Oct 01, 2018
Jkt 247001
Notice that the charter of the
Coordinating Council on Juvenile
Justice and Delinquency Prevention has
been renewed.
FOR FURTHER INFORMATION CONTACT: Visit
the website for the Coordinating Council
at www.juvenilecouncil.gov or contact
Jeff Slowikowski, Designated Federal
Official (DFO), Office of Juvenile Justice
and Delinquency Prevention, by
telephone at (202) 616–3646 (not a tollfree number) or via email:
jeff.slowikowski@usdoj.gov.
SUPPLEMENTARY INFORMATION: This
Federal Register Notice notifies the
public that the Charter of the
Coordinating Council on Juvenile
Justice and Delinquency has been
renewed in accordance with the Federal
Advisory Committee Act, Section
14(a)(1). The renewal Charter was
signed by U.S. Attorney General
Jefferson B. Sessions on June 29, 2018.
One can obtain a copy of the renewal
Charter by accessing the Coordinating
Council on Juvenile Justice and
Delinquency Prevention’s website at
www.juvenilecouncil.gov.
SUMMARY:
Importer of Controlled Substances
Registration
amozie on DSK3GDR082PROD with NOTICES1
schedule I or II controlled substances to
the above listed company.
Jeff Slowikowski,
Senior Advisor to the Coordinating Council
on Juvenile Justice and Delinquency
Prevention, Office of Juvenile Justice and
Delinquency Prevention.
[FR Doc. 2018–21379 Filed 10–1–18; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Parole Commission
Sunshine Act Meetings
Record of Vote of Meeting Closure
(Pub. L. 94–409) (5 U.S.C. 552b)
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
49581
I, Patricia K. Cushwa, of the United
States Parole Commission, was present
at a meeting of said Commission, which
started at approximately 1:30 p.m., on
Wednesday, September 26, 2018 at the
U.S. Parole Commission, 90 K Street NE,
Third Floor, Washington, DC 20530.
The purpose of the meeting was to
discuss original jurisdiction cases
pursuant to 28 CFR 2.25. and 28 CFR
2.68(i)(1) Two Commissioners were
present, constituting a quorum when the
vote to close the meeting was submitted.
Public announcement further
describing the subject matter of the
meeting and certifications of the General
Counsel that this meeting may be closed
by votes of the Commissioners present
were submitted to the Commissioners
prior to the conduct of any other
business. Upon motion duly made,
seconded, and carried, the following
Commissioners voted that the meeting
be closed: Patricia K. Cushwa and
Charles T. Massarone.
In witness whereof, I make this official
record of the vote taken to close this
meeting and authorize this record to be
made available to the public.
Dated: September 26, 2018.
Patricia K. Cushwa,
Acting Chairperson, U.S. Parole Commission.
[FR Doc. 2018–21566 Filed 9–28–18; 4:15 pm]
BILLING CODE 4410–31–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (18–072)]
Notice of Intent To Grant Exclusive
Term License
National Aeronautics and
Space Administration.
ACTION: Notice of intent to grant an
exclusive term license.
AGENCY:
NASA hereby gives notice of
its intent to grant an exclusive term
license in the United States to practice
the invention described and claimed in
U.S. Patent No. 9,749,342 entitled,
‘‘System and Method for Detecting
Unauthorized Device Access by
Comparing Multiple Independent
Spatial-Time Data Sets from Other
Devices’’ to Equator Corporation, having
its principal place of business in
Stafford, VA.
DATES: The prospective exclusive
license may be granted unless NASA
receives written objections, including
evidence and argument October 17,
2018, that establish that the grant of the
license would not be consistent with the
requirements regarding the licensing of
federally owned inventions as set forth
SUMMARY:
E:\FR\FM\02OCN1.SGM
02OCN1
Agencies
[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Pages 49580-49581]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21334]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: R & D Systems,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before November 1, 2018.
Such persons may also file a written request for a hearing on the
application on or before November 1, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearings must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearings should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on April
9, 2018, R & D Systems, Inc., 614 McKinley Place NE, Minneapolis,
Minnesota 55413-5541 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-methylcathinone).. 1248 I
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
Marihuana................................ 7360 I
Tetrahydrocannabinols.................... 7370 I
4-Bromo-2,5-dimethoxyamphetamine......... 7391 I
3,4-Methylenedioxymethamphetamine........ 7405 I
Dimethyltryptamine....................... 7435 I
Psilocyn................................. 7438 I
Pentobarbital............................ 2270 II
Phencyclidine............................ 7471 II
Cocaine.................................. 9041 II
------------------------------------------------------------------------
[[Page 49581]]
The company plans to import bulk active controlled substances for
distribution to its customers for research and analytical purposes. In
reference to drug codes marihuana (7360) and tetrahydrocannabinols
(7370) the company plans to import a synthetic cannabidiol and a
synthetic tetrahydrocannabinol. No other activity for these drug codes
is authorized for this registration.
Dated: September 20, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-21334 Filed 10-1-18; 8:45 am]
BILLING CODE 4410-09-P